Table 2.
Baseline characteristics and clinical data of patients with idiopathic membranous nephropathy at the time of renal biopsy*
| Characteristic | IMN patients*(n = 67) | No Thromboembolic events (n = 53) | Thromboembolic events (n = 14) | P-value |
|---|---|---|---|---|
| Age (years) |
58.3 ± 16.7 |
58.6 ± 16.7 |
57.3 ± 17.4 |
NS |
| Sex, male,n (%) |
42 (63%) |
38 (73%) |
11 (78.5%) |
NS |
| Ethnicity, n (%) |
|
|
|
|
| Caucasians |
39 (59%) |
31 (60%) |
8 (58%) |
NS |
| Afro-Carribeans |
11 (16%) |
09 (17%) |
2 (14%) |
NS |
| South Asians |
09 (13%) |
07 (14%) |
2 (14%) |
NS |
| Middle-East |
08 (12%) |
05 (09%) |
2 (14%) |
NS |
| Duration of follow-up (years) |
7.2 ± 3 |
7.1 ± 3 |
7.8 ± 3.2 |
NS |
| s.creatinine (mg/dl) |
1.24 ± 0.8 |
1.23 ± 0.7 |
1.28 ± 0.8 |
NS |
| s.albumin (g/dl) |
2.3 ± 0.4 |
2.4 ± 0.4 |
1.9 ± 0.5 |
< 0.01 |
| s.cholesterol (mg/dl) |
336 ± 128 |
317 ± 108 |
414 ± 124 |
0.01 |
| eGFR (ml/min per 1.73 m2) |
65 ± 27 |
66 ± 25 |
62 ± 29 |
NS |
| Proteinuria (g/24 h) |
7.9 ± 3.5 |
7.1 ± 4 |
10.7 ± 3 |
<0.01 |
| Immuno-suppresion | 49 (73.1%) | 35 (66%) | 12 (86%) |
* IMN patients with complete data (n = 67/78, 85.8%): IMN patients with no TE and with TE, 84% (n = 53/63) and 93% (n = 14/15); respectively.